Impact Report 2022
2022 was an incredible year of fundraising, innovation and community spirit at JDRF Canada. We marked the 100th anniversary of the first successful injection of insulin, and while we celebrated the historical discovery that finally gave hope to people with type 1 diabetes (T1D), it renewed our intensity and fuelled us even more to move beyond insulin and closer to cures.
Past Annual Impact Reports
Annual Impact Report 2021
Annual Impact Report 2020
Annual Impact Report 2019
Annual Impact Report 2018
Annual Impact Report 2017
Annual Impact Report 2016
Annual Impact Report 2015
Annual Impact Report 2014
Annual Impact Report 2013
Annual Impact Report 2012
Consolidated Financial Statements
Consolidated Financial Statements 2022
Consolidated Financial Statements 2021
Consolidated Financial Statements 2020
Consolidated Financial Statements 2019
Consolidated Financial Statements 2018
Consolidated Financial Statements 2017
Consolidated Financial Statements 2016
Consolidated Financial Statements 2015
Consolidated Financial Statements 2014
Consolidated Financial Statements 2013
Consolidated Financial Statements 2012
Stay connected on the latest
My first question after my diagnosis was, “Can I still play hockey?” I was scared it might be off the table for me.
With JDRF-funded research, I’m incredibly hopeful for the future. That’s why JDRF’s mission to advance T1D research is so important to me. I want to do whatever I can to make life better for Canadians with this disease.
Diagnosed at age 12
What if my child with T1D didn’t have to worry about health complications? It would be a life full of happiness and peace, without any fear.
Today is better than yesterday, and tomorrow will be better than today.
Nisha and Rohan
Rohan, diagnosed at age 4